Product Code: GVR-4-68040-029-4
Telerehabilitation Market Growth & Trends:
The global telerehabilitation market size is expected to reach USD 11.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.3 % from 2023 to 2030. One of the main factors anticipated to propel the telerehabilitation industry is the increasing usage of digital technologies in the healthcare sector owing to the expanding use of smartphones and the internet globally.
Patients with mobility problems, such as those with motor, neurological, and sensory functions, can benefit from telerehabilitation services. People become increasingly susceptible to chronic disease and physiological dysfunction as they get older. This further emphasizes the need for high-quality medical assistance. Telerehabilitation facilitates fast treatments and makes services more accessible for the elderly population, who find it challenging to get rehabilitation services due to mobility issues. As per the World Health Organization, there will be approximately 1.2 billion individuals over the age of 60 by 2025, and this number is anticipated to raise to 2.0 billion by 2050. Additionally, it is projected that the aging population and those with chronic illnesses will boost the market demand.
Due to the COVID-19 pandemic's restrictions, postponement of non-essential treatments, and transformation of wards into COVID wards to address the increasing number of patients, the telerehabilitation services witnessed a considerable increase. For instance, as per a research article that was published in JCO Global Oncology-An American Society of Clinical Oncology Journal, 2020 physical distance was maintained during the COVID-19 pandemic to reduce the spread of the disease. As a result, telerehabilitation was used for most outpatient oncology appointments.
Further, various initiatives undertaken to strengthen the market is impelling the growth. For instance, according to a report by the NCBI (National Center for Biotechnology Information), the Sheikh Khalifa Stroke Institute in the United Arab Emirates collaborated with Johns Hopkins Medicine to support the development of telerehabilitation kits and the full implementation of the Mind Motion GO technology in 2022.
Telerehabilitation Market Report Highlights:
- In 2022, the software segment held the largest share of 60.8% owing to the rising adoption of software to efficiently manage organizational workflows. Also, many software solutions are developed to address home-based rehabilitation programs, which is adding fuel to the segment growth
- In 2022, clinical therapy accounted for 60.5% of the revenue and owing to rising demand for telerehabilitation for physical therapy, occupational therapy, cognitive function, etc. The rehabilitation services have resulted in improved outcomes, which is positively impacting the market growth
- In 2022, orthopedic application segment dominated the market with a revenue share of 32.5% owing to rising orthopedic surgeries across the globe and increasing adoption of telerehabilitation services by orthopedic surgeons
- In 2022, physical therapy accounted for 42.2% of the revenue owing to its various benefits. It provides a personalized program for the patient's condition and is convenient with no travel costs and time
- In 2022, North America accounted for 41.6% of the revenue due to well-developed healthcare infrastructure, increased prevalence of chronic diseases, and various initiatives were undertaken to promote the adoption of telerehabilitation services
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definition
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.1.1. Purchased database:
- 1.3.1.2. GVR's internal database
- 1.3.2. Primary Research:
- 1.4. Research Scope and Assumptions
- 1.5. List to Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- 2.4. Telerehabilitation Market
Chapter 3. Telerehabilitation Market Variables, Trends, & Scope
- 3.1. Penetration and Growth Prospect Mapping
- 3.2. Market Dynamics
- 3.3. Telerehabilitation Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Telerehabilitation Market: Component Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.2. Telerehabilitation Market: Component Movement Analysis, USD Million, 2022 & 2030
- 4.3. Hardware
- 4.3.1. Hardware market estimates and forecasts, 2018- 2030 (USD Million)
- 4.4. Software
- 4.4.1. Software market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Telerehabilitation Market: Services Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.2. Telerehabilitation Market: Services Movement Analysis, USD Million, 2022 & 2030
- 5.3. Clinical assessment
- 5.3.1. Clinical assessment market estimates and forecasts, 2018- 2030 (USD Million)
- 5.4. Clinical therapy
- 5.4.1. Clinical therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Telerehabilitation Market: Therapy Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.2. Telerehabilitation Market: Therapy Movement Analysis, USD Million, 2022 & 2030
- 6.3. Physical therapy
- 6.3.1. Physical therapy market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4. Occupational therapy
- 6.4.1. Occupational therapy market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.5. Others
- 6.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Telerehabilitation Market: Application Estimates & Trend Analysis
- 7.1. Definitions and Scope
- 7.2. Telerehabilitation Market: Application Movement Analysis, USD Million, 2022 & 2030
- 7.3. Cardiovascular
- 7.3.1. Cardiovascular market estimates and forecasts, 2018- 2030 (USD Million)
- 7.4. Orthopedic
- 7.4.1. Orthopedic market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5. Neurology
- 7.5.1. Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6. Pediatric
- 7.6.1. Pediatric market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7. Others
- 7.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Telerehabilitation Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Snapshot
- 8.2. Telerehabilitation Market: Regional Movement Analysis
- 8.3. North America
- 8.3.1. North America market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.3.2. North America market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.3.3. North America market estimates and forecasts, by service 2018 - 2030 (USD Million)
- 8.3.4. North America market estimates and forecasts, by therapy 2018 - 2030 (USD Million
- 8.3.5. North America market estimates and forecasts, by application 2018 - 2030 (USD Million
- 8.3.6. U.S.
- 8.3.6.1. U.S. market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.3.6.2. U.S. market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.3.6.3. U.S. market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.3.6.4. U.S. market estimates and forecasts, by therapy 2018 - 2030 (USD Million
- 8.3.6.5. U.S. market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.3.7. Canada
- 8.3.7.1. Canada market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.3.7.2. Canada market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.3.7.3. Canada market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.3.7.4. Canada market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.3.7.5. Canada market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.4. Europe
- 8.4.1. Europe market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.4.2. Europe market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.4.3. Europe market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.4.4. Europe market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.4.5. Europe market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.4.6. Germany
- 8.4.6.1. Germany market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.4.6.2. Germany market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.4.6.3. Germany market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.4.6.4. Germany market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.4.6.5. Germany market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.4.7. U.K.
- 8.4.7.1. U.K market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.4.7.2. U.K market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.4.7.3. U.K market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.4.7.4. U.K market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.4.7.5. U.K market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.4.8. France
- 8.4.8.1. U.K market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.4.8.2. U.K market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.4.8.3. U.K market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.4.8.4. U.K market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.4.8.5. U.K market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.4.9. Italy
- 8.4.9.1. Italy market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.4.9.2. Italy market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.4.9.3. Italy market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.4.9.4. Italy market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.4.9.5. Italy market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.4.10. Spain
- 8.4.10.1. Spain market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.4.10.2. Spain market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.4.10.3. Spain market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.4.10.4. Spain market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.4.10.5. Spain market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.4.11. Russia
- 8.4.11.1. Russia market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.4.11.2. Russia market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.4.11.3. Russia market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.4.11.4. Russia market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.4.11.5. Russia market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.5.2. Asia Pacific market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.5.3. Asia Pacific market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.5.4. Asia Pacific market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.5.5. Asia Pacific market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.5.6. Asia Pacific market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.5.7. Japan
- 8.5.7.1. Japan market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.5.7.2. Japan market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.5.7.3. Japan market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.5.7.4. Japan market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.5.7.5. Japan market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.5.8. China market estimates and forecasts, by application 2017 - 2030 (USD Million)
- 8.5.8.1. China market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.5.8.2. China market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.5.8.3. China market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.5.8.4. China market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.5.8.5. China market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.5.9. India market estimates and forecasts, by application 2017 - 2030 (USD Million)
- 8.5.9.1. India market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.5.9.2. India market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.5.9.3. India market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.5.9.4. India market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.5.9.5. India market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.5.10. Australia
- 8.5.10.1. Australia market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.5.10.2. Australia market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.5.10.3. Australia market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.5.10.4. Australia market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.5.10.5. Australia market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.5.11. South Korea
- 8.5.11.1. South Korea market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.5.11.2. South Korea market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.5.11.3. South Korea market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.5.11.4. South Korea market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.5.11.5. South Korea market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.6.2. Latin America market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.6.3. Latin America market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.6.4. Latin America market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.6.5. Latin America market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.6.6. Brazil
- 8.6.6.1. Brazil market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.6.6.2. Brazil market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.6.6.3. Brazil market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.6.6.4. Brazil market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.6.6.5. Brazil market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.6.7. Mexico
- 8.6.7.1. Mexico market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.6.7.2. Mexico market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.6.7.3. Mexico market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.6.7.4. Mexico market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.6.7.5. Mexico market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.6.8. Argentina
- 8.6.8.1. Argentina market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.6.8.2. Argentina market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.6.8.3. Argentina market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.6.8.4. Argentina market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.6.8.5. Argentina market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.7. MEA
- 8.7.1. MEA market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.7.2. MEA market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.7.3. MEA market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.7.4. MEA market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.7.5. MEA market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.7.6. South Africa
- 8.7.6.1. South Africa market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.7.6.2. South Africa market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.7.6.3. South Africa market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.7.6.4. South Africa market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.7.6.5. South Africa market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.7.7. Saudi Arabia
- 8.7.7.1. Saudi Arabia market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.7.7.2. Saudi Arabia market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.7.7.3. Saudi Arabia market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.7.7.4. Saudi Arabia market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.7.7.5. Saudi Arabia market estimates and forecasts, by application 2018 - 2030 (USD Million)
- 8.7.8. UAE
- 8.7.8.1. UAE market estimates and forecasts, by country 2018 - 2030 (USD Million)
- 8.7.8.2. UAE market estimates and forecasts, by component 2018 - 2030 (USD Million)
- 8.7.8.3. UAE market estimates and forecasts, by service 2018 - 2030 (USD Million
- 8.7.8.4. UAE market estimates and forecasts, by therapy 2018 - 2030 (USD Million)
- 8.7.8.5. UAE market estimates and forecasts, by application 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. Public Companies
- 9.3.2. Private Companies
Chapter 10. Competitive Landscape
- 10.1. American Well
- 10.1.1. Company overview
- 10.1.2. Financial performance
- 10.1.3. Product benchmarking
- 10.1.4. Strategic initiatives
- 10.2. Doctor On Demand, Inc
- 10.2.1. Company overview
- 10.2.2. Financial performance
- 10.2.3. Product benchmarking
- 10.2.4. Strategic initiatives
- 10.3. Hinge Health, Inc.
- 10.3.1. Company overview
- 10.3.2. Financial performance
- 10.3.3. Product benchmarking
- 10.3.4. Strategic initiatives
- 10.4. MIRA Rehab Limited
- 10.4.1. Company overview
- 10.4.2. Financial performance
- 10.4.3. Product benchmarking
- 10.4.4. Strategic initiatives
- 10.5. Koninklijke Philips N.V
- 10.5.1. Company overview
- 10.5.2. Financial performance
- 10.5.3. Product benchmarking
- 10.5.4. Strategic initiatives
- 10.6. Cisco
- 10.6.1. Company overview
- 10.6.2. Financial performance
- 10.6.3. Product benchmarking
- 10.6.4. Strategic initiatives
- 10.7. NeoRehab
- 10.7.1. Company overview
- 10.7.2. Financial performance
- 10.7.3. Product benchmarking
- 10.7.4. Strategic initiatives
- 10.8. Jintronix
- 10.8.1. Company overview
- 10.8.2. Financial performance
- 10.8.3. Product benchmarking
- 10.8.4. Strategic initiatives
- 10.9. C3O telemedicine
- 10.9.1. Company overview
- 10.9.2. Financial performance
- 10.9.3. Product benchmarking
- 10.9.4. Strategic initiatives
- 10.10. Care Innovation, LLC.
- 10.10.1. Company overview
- 10.10.2. Financial performance
- 10.10.3. Product benchmarking
- 10.10.4. Strategic initiatives
- 10.11. Bosch Healthcare
- 10.11.1. Company overview
- 10.11.2. Financial performance
- 10.11.3. Product benchmarking
- 10.11.4. Strategic initiatives
- 10.12. Cloud Physio
- 10.12.1. Company overview
- 10.12.2. Financial performance
- 10.12.3. Product benchmarking
- 10.12.4. Strategic initiatives
- 10.13. Medvivo Group
- 10.13.1. Company overview
- 10.13.2. Financial performance
- 10.13.3. Product benchmarking
- 10.13.4. Strategic initiatives